Skip to content

Controlled Drugs and Substances Act

S.C. 1996, c. 19

In forceCurrent to September 30, 2026 History

Follow

SCHEDULE V

Amended on June 5, 2026

SCHEDULE V(Sections 2, 5 to 7.1, 10, 55, 60.1 and 60.2)

PART 1
Controlled Substances

Column 1Column 2
ItemSubstancePeriod
1Spirobrorphine (8-[1-(4-bromophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one) and its saltsJune 5, 2026 to June 4, 2027
2Spirochlorphine (8-[1-(4-chlorophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one) and its saltsJune 5, 2026 to June 4, 2027

PART 2
Precursors

TABLE 1 — Class A Precursors

Column 1Column 2
ItemSubstancePeriod
1R 29676 (5-chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) and its saltsJune 5, 2026 to June 4, 2027
2

[Repealed, 1996, c. 19, s. 60.1]

TABLE 2 — Class B Precursors

Column 1Column 2
ItemSubstancePeriod
1

[Repealed, 1996, c. 19, s. 60.1]

TABLE 3 — Preparations and Mixtures Containing Precursors

Column 1Column 2
ItemSubstancePeriod
1Any preparation or mixture that contains R 29676 (5-chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) or its saltsJune 5, 2026 to June 4, 2027
2

[Repealed, 1996, c. 19, s. 60.1]

3

[Repealed, 1996, c. 19, s. 60.1]

  • 1996, c. 19, s. 60.1
  • 1996, c. 19, Sch. V
  • SOR/2002-361, s. 1
  • SOR/2003-32, s. 7
  • 2017, c. 7, s. 50
  • SOR/2022-185, s. 1
  • SOR/2022-185, s. 2
  • SOR/2025-64, s. 1
  • SOR/2025-64, s. 2
  • 2026, c. 4, s. 10
  • 2026, c. 4, s. 21
  • SOR/2026-71, s. 1
  • SOR/2026-71, s. 2
  • SOR/2026-71, s. 3
.

Amended by SOR/2026-71, s. 3, in force on June 5, 2026Bills:C-12 (2026, c. 4)

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.